Sino Biopharmaceutical Ltd
HKEX:1177

Watchlist Manager
Sino Biopharmaceutical Ltd Logo
Sino Biopharmaceutical Ltd
HKEX:1177
Watchlist
Price: 3.22 HKD 0.31% Market Closed
Market Cap: 60.5B HKD
Have any thoughts about
Sino Biopharmaceutical Ltd?
Write Note
Sino Biopharmaceutical Ltd
/
Income Statement
/
Other Operating Expenses

Sino Biopharmaceutical Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sino Biopharmaceutical Ltd
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Sino Biopharmaceutical Ltd
HKEX:1177
Other Operating Expenses
¥59.9m
CAGR 3-Years
-45%
CAGR 5-Years
8%
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Other Operating Expenses
HK$233.6m
CAGR 3-Years
-11%
CAGR 5-Years
1%
CAGR 10-Years
8%
U
United Laboratories International Holdings Ltd
HKEX:3933
Other Operating Expenses
¥80.8m
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
-9%
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Other Operating Expenses
¥183.9m
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
29%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Other Operating Expenses
HK$2.4B
CAGR 3-Years
18%
CAGR 5-Years
7%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sino Biopharmaceutical Ltd
Glance View

Market Cap
59B HKD
Industry
Pharmaceuticals

Sino Biopharmaceutical Ltd. emerged as a key player in the Chinese healthcare landscape, rooted in the rich cultural hubs of Beijing and Hong Kong. As the tapestry of modern medicine interweaves ever more tightly with advanced research, Sino Biopharmaceutical positions itself at this critical juncture. The company delves extensively into the discovery, development, manufacturing, and commercialization of a broad spectrum of pharmaceuticals. With a keen focus on therapeutic areas like oncology, hepatitis, and cardio-cerebral diseases, they forge pathways for innovative treatments that resonate widely in the fast-developing Chinese medical market. Driven by its Research and Development prowess, Sino Biopharmaceutical garners considerable strength from its portfolio of proprietary drugs, underscoring a growth strategy deeply rooted in innovation and quality. The financial blueprint of Sino Biopharmaceutical delicately balances its expansive production capacities with a robust distribution network, encapsulating an effective end-to-end operation from lab to patient. Revenue streams are predominantly anchored in its extensive sales of prescription drugs, particularly high-margin specialty pharmaceuticals that address critical and chronic health conditions. Leveraging strategic alliances and collaborations with both domestic and international partners, the company enhances its technological capabilities and global reach. Moreover, its enduring commitment to sustainable practices and compliance wields influence over its operational efficiencies, allowing Sino Biopharmaceutical to navigate and capitalize on regulatory environments while meeting the burgeoning healthcare needs across its business region.

Intrinsic Value
3.97 HKD
Undervaluation 19%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Sino Biopharmaceutical Ltd's Other Operating Expenses?
Other Operating Expenses
59.9m CNY

Based on the financial report for Jun 30, 2024, Sino Biopharmaceutical Ltd's Other Operating Expenses amounts to 59.9m CNY.

What is Sino Biopharmaceutical Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
8%

Over the last year, the Other Operating Expenses growth was -73%. The average annual Other Operating Expenses growth rates for Sino Biopharmaceutical Ltd have been -45% over the past three years , 8% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.